Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
30
JSHG Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
5.11%
Day range:
$0.0039 - $0.0039
52-week range:
$0.0020 - $0.0099
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
58.9K
1-year change:
-49.35%
Market cap:
$805.3K
Revenue:
--
EPS (TTM):
--
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $499.5K | $109.1K | $42.3K | $13.4K | $9.5K | |
| Other Inc / (Exp) | -$288.9K | -- | -- | -- | -- | |
| Operating Expenses | $687.8K | $191.6K | $174K | $156.5K | $153.3K | |
| Operating Income | -$687.8K | -$191.6K | -$174K | -$156.5K | -$153.3K | |
| Net Interest Expenses | $24K | $14.1K | $115.3K | $131.3K | $150.6K | |
| EBT. Incl. Unusual Items | -$1M | -$215.4K | -$489.5K | -$264.3K | -$323.7K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$1M | -$593K | -$489.5K | -$264.3K | -$323.7K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1M | -$215.4K | -$489.5K | -$264.3K | -$323.7K | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Weighted Average Basic Share | $151M | $153M | $192.8M | $206.3M | $221.9M | |
| Weighted Average Diluted Share | $151M | $153M | $192.8M | $206.3M | $221.9M | |
| EBITDA | -$687.8K | -$191.6K | -$174K | -$156.5K | -$153.3K | |
| EBIT | -$687.8K | -$191.6K | -$174K | -$156.5K | -$153.3K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$687.8K | -$191.6K | -$174K | -$156.5K | -$153.3K | |
| Operating Income (Adjusted) | -$687.8K | -$191.6K | -$174K | -$156.5K | -$153.3K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $214.8K | $27.6K | $33.6K | $4.4K | $2.4K | |
| Other Inc / (Exp) | -$117.2K | -- | -- | -- | -- | |
| Operating Expenses | $215.5K | $90.2K | $82.2K | $29K | $34.9K | |
| Operating Income | -$215.5K | -$90.2K | -$82.2K | -$29K | -$34.9K | |
| Net Interest Expenses | -- | $7.2K | $8.5K | $46.6K | $37.3K | |
| EBT. Incl. Unusual Items | -$340.2K | -$105.3K | -$203.2K | -$79.5K | -$77.9K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$340.2K | -$104.4K | -$400 | -$78.5K | -$80.6K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$340.2K | -$105.3K | -$203.2K | -$79.5K | -$77.9K | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Weighted Average Basic Share | $149.6M | $153M | $176.6M | $205.2M | $229.3M | |
| Weighted Average Diluted Share | $149.6M | $153M | $176.6M | $205.2M | $229.3M | |
| EBITDA | -$332.7K | -$90.2K | -$82.2K | -$29K | -$34.9K | |
| EBIT | -$332.7K | -$90.2K | -$82.2K | -$29K | -$34.9K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$215.5K | -$90.2K | -$82.2K | -$29K | -$34.9K | |
| Operating Income (Adjusted) | -$332.7K | -$90.2K | -$82.2K | -$29K | -$34.9K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $454.1K | $540.4K | $379.6K | $21.7K | $21.5K | |
| Other Inc / (Exp) | -$440.3K | -- | -- | -- | -- | |
| Operating Expenses | $517K | $729.9K | $605.9K | $122.8K | $175.5K | |
| Operating Income | -$501.7K | -$729.9K | -$605.9K | -$122.8K | -$175.5K | |
| Net Interest Expenses | -- | $32.9K | $31.2K | $177.6K | $184.2K | |
| EBT. Incl. Unusual Items | -$965.1K | -$1.1M | -$880K | -$322.5K | -$337.4K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$965.1K | -$738.3K | -$460.9K | -$519.9K | -$335.4K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$965.1K | -$1.1M | -$880K | -$322.5K | -$337.4K | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.01 | -$0.01 | -$0.00 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.01 | -$0.01 | -$0.00 | -$0.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$941.9K | -$729.9K | -$605.9K | -$122.8K | -$175.5K | |
| EBIT | -$941.9K | -$729.9K | -$605.9K | -$122.8K | -$175.5K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$501.7K | -$729.9K | -$605.9K | -$122.8K | -$175.5K | |
| Operating Income (Adjusted) | -$941.9K | -$729.9K | -$605.9K | -$122.8K | -$175.5K | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $109.1K | $203.6K | $7.9K | $4.7K | -- | |
| Other Inc / (Exp) | -$1.8K | -- | -- | -- | -- | |
| Operating Expenses | $197.5K | $299.2K | $55.1K | $74.1K | -- | |
| Operating Income | -$197.5K | -$299.2K | -$55.1K | -$74.1K | -- | |
| Net Interest Expenses | $14.1K | $16.5K | $78.7K | $73.4K | -- | |
| EBT. Incl. Unusual Items | -$221.3K | -$502.5K | -$142.6K | -$157.5K | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$214.6K | -$106.8K | -$141.6K | -$160.2K | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$221.3K | -$502.5K | -$142.6K | -$157.5K | -- | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -- | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -- | |
| Weighted Average Basic Share | $306.6M | $343.8M | $405.2M | $439M | -- | |
| Weighted Average Diluted Share | $306.6M | $343.8M | $405.2M | $439M | -- | |
| EBITDA | -$197.5K | -$299.2K | -$55.1K | -$74.1K | -- | |
| EBIT | -$197.5K | -$299.2K | -$55.1K | -$74.1K | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$197.5K | -$299.2K | -$55.1K | -$74.1K | -- | |
| Operating Income (Adjusted) | -$197.5K | -$299.2K | -$55.1K | -$74.1K | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $300 | $13.5K | $2K | $600 | $100 | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $11K | -- | -- | -- | $8.7K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $88.3K | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $110.2K | $28.5K | $7.5K | $9.6K | $8.8K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $110.2K | $28.5K | $7.5K | $9.6K | $8.8K | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $27.3K | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $198.6K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5M | $1.7M | $1.8M | $1.9M | $2.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.5M | $1.7M | $1.8M | $1.9M | $2.1M | |
| Common Stock | $15.3K | $17.2K | $20.5K | $21.9K | $24.4K | |
| Other Common Equity Adj | $51.6K | -- | -- | -- | -- | |
| Common Equity | -$1.4M | -$1.6M | -$1.8M | -$1.9M | -$2.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.4M | -$1.6M | -$1.8M | -$1.9M | -$2.1M | |
| Total Liabilities and Equity | $110.2K | $28.5K | $7.5K | $9.5K | $8.8K | |
| Cash and Short Terms | $300 | $13.5K | $2K | $600 | $100 | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.7K | $19.6K | $14.8K | $8.6K | $8.2K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $13.3K | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $366.7K | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $410.7K | $30.7K | $20.7K | $16.2K | $16.2K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $410.7K | $30.7K | $20.7K | $16.2K | $16.2K | |
| Accounts Payable | $303.4K | -- | -- | -- | -- | |
| Accrued Expenses | $13.6K | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $666.1K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4M | $1.6M | $1.7M | $1.9M | $2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4M | $1.6M | $1.7M | $1.9M | $2M | |
| Common Stock | $15.1K | $15.5K | $18.4K | $20.5K | $22.9K | |
| Other Common Equity Adj | $39.7K | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1M | -$1.5M | -$1.7M | -$1.8M | -$2M | |
| Total Liabilities and Equity | $410.7K | $30.7K | $20.8K | $16.1K | $16.2K | |
| Cash and Short Terms | $11.7K | $19.6K | $14.8K | $8.6K | $8.2K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1M | -$593K | -$489.5K | -$264.3K | -$323.7K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $116.4K | $137.5K | $122K | $106.2K | $121K | |
| Change in Accounts Receivable | $8.7K | $6.6K | $9.5K | -$3.5K | $300 | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$65.4K | -$105K | -$43.9K | -$81.2K | -$26.2K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.5K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $26.9K | -- | -- | -- | -- | |
| Cash From Financing | $56.2K | $76.6K | $29.9K | $120.7K | $34K | |
| Beginning Cash (CF) | $300 | $13.5K | $2K | $600 | $100 | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.4K | -$18.7K | -$12K | -$1.4K | -$500 | |
| Ending Cash (CF) | $2.7K | $4.5K | -$7.9K | -$41.8K | -$8.6K | |
| Levered Free Cash Flow | -$65.4K | -$105K | -$43.9K | -$81.2K | -$26.2K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$340.2K | -$104.4K | -$400 | -$78.5K | -$80.6K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $30K | $39.8K | $100 | $22.2K | $31.1K | |
| Change in Accounts Receivable | -$1.6K | $100 | -- | -$1.2K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$49.4K | -$1.9K | $112.9K | -$8.9K | $8.4K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $35K | -- | -- | -- | -- | |
| Cash From Financing | $35K | $18.3K | -- | -- | $200 | |
| Beginning Cash (CF) | $15.2K | $19.6K | $14.8K | $8.6K | $8.2K | |
| Foreign Exchange Rate Adjustment | $11K | -- | -$112.9K | $28.1K | -$5.8K | |
| Additions / Reductions | -$14.4K | $16.4K | -- | $19.2K | $2.9K | |
| Ending Cash (CF) | $11.7K | $36K | -$98.2K | $56K | $5.4K | |
| Levered Free Cash Flow | -$49.4K | -$1.9K | $112.9K | -$8.9K | $8.4K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$965.1K | -$738.3K | -$460.9K | -$519.9K | -$335.4K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $165K | $76.8K | $122.5K | $126.2K | $122.9K | |
| Change in Accounts Receivable | $10.2K | $21.1K | -$4.1K | $7.3K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$102.4K | -$31.6K | $30K | -$161.9K | -$53.9K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $121.5K | -- | -- | -- | -- | |
| Cash From Financing | $121.5K | $49.7K | $16.7K | $28.6K | $129.8K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.2K | $7.7K | -$26.7K | $5.2K | $30.4K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$102.4K | -$31.5K | $30K | -$161.8K | -$53.9K | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$214.6K | -$106.8K | -$141.6K | -$160.2K | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $47.3K | $37.9K | $43.2K | $62.1K | -- | |
| Change in Accounts Receivable | $10.4K | -- | -$2K | $600 | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$34.3K | $99.7K | -$18.7K | $4.3K | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $41.5K | -- | -- | -- | -- | |
| Cash From Financing | $59.8K | $3K | $2K | $13.5K | -- | |
| Beginning Cash (CF) | $22.7K | $17.9K | $9.5K | $13.7K | -- | |
| Foreign Exchange Rate Adjustment | -$6.3K | -$113.1K | $23.3K | -$10.2K | -- | |
| Additions / Reductions | $19.2K | -$10.4K | $6.6K | $7.8K | -- | |
| Ending Cash (CF) | $35.6K | -$105.8K | $39.5K | $11.4K | -- | |
| Levered Free Cash Flow | -$34.3K | $99.7K | -$18.7K | $4.3K | -- | |
Related Companies
Get JSHG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JSHG
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
JSHG
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
JSHG
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
Feb
12
Estimated Next Earnings Date
May
14
Balance Sheet
JSHG
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$8.8K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 18.79% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 5.08% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 5.06% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
